>> View All Results for ""
Enter multiple symbols separated by commas
London quotes now available
Questcor is a rare growth biotech, says Mad Money's Cramer, with a spectacular 42% growth rate, selling at 23 times earnings. Discussing the company's outlook, with Donald Bailey, Questcor Pharmaceuticals, Inc. CEO.